2010nccn肾癌

NCCN代表：
Timothy M. Kuzel, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University
成 员（按拼音排序）：
陈 嘉 江苏省肿瘤医院 何志嵩 北京大学附属第一医院 黄翼然 上海交通大学医学院附属仁济医院 焦顺昌 中国人民解放军总医院（三〇一医院） 李 鸣 北京大学临床肿瘤学院、北京肿瘤医院 孙 光 天津医科大学附属第二医院 孙颖浩 第二军医大学附属长海医院 王金万 中国医学科学院北京协和医学院肿瘤医院 谢晓冬 沈阳军区总医院 叶定伟 复旦大学附属肿瘤医院 叶章群 华中科技大学同济医学院附属同济医院 于世英 华中科技大学同济医学院附属同济医院 张沂平 浙江省肿瘤医院 周芳坚 中山大学附属肿瘤医院
NCCN
®
肿瘤学临床实践指南(中国版) 2010年 第一版
肾癌
NCCN肾癌专家组成员
* Robert J. Motzer, MD/Chair † Þ Memorial Sloan-Kettering Cancer Center Neeraj Agarwal, MD ‡ Huntsman Cancer Institute at the University of Utah Clair Beard, MD § Dana-Farber/Brigham and Women’s Cancer Center Sam Bhayani, MD ω Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine Graeme B. Bolger, MD † University of Alabama at Birmingham Comprehensive Cancer Center Barry Boston, MD † £ St. Jude Children’s Research Hospital/University of Tennessee Cancer Institute Michael A. Carducci, MD † Þ The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Sam S. Chang, MD ω Vanderbilt-Ingram Cancer Center Toni K. Choueiri, MD † Þ Dana-Farber/Brigham and Women’s Cancer Center Robert A. Figlin, MD † City of Hope Comprehensive Cancer Certer
† 肿瘤内科 ‡ 血液科/血液肿瘤科 § 放射治疗/肿瘤放射科 ф 诊断放射科 £ 支持治疗，包括姑息治疗、 疼痛治疗、 关怀治疗和肿瘤社会工作 Þ 内科 ω 泌尿科 * 编委会成员
© National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN. The Chinese edition 2010 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive Cancer Network. To view the most recent and complete version of this or any other guideline, visit .
Copyright © National Comprehensive Cancer Network 2010. All rights reserved. “NCCN”, the NCCN logo, and “National Comprehensive Cancer Network” are registered trademarks of the National Comprehensive Cancer Network. The Chinese edition of NCCN Clinical Practice Guidelines in Oncology-Kidney Cancer Guideline 2010 is the Chinese adapted version of NCCN Clinical Practice Guidelines in Oncology-Kidney Cancer Guideline, V.2.2010 as permitted and endorsed by NCCN. It is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. The original guideline and Chinese edition are both available at: . To view the most recent and complete version of the guideline, go online to . These Guidelines and illustrations herein may not be reproduced in any form for any purpose without the express written permission of the NCCN. These Guidelines are a work in progress that will be refined as often as new significant data becomes available. The NCCN Guidelines are a statement of consensus of its authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult any NCCN guideline is expected to use independent medical judgment in the context of individual clinical circumstance to determine any patient's care or treatment. The National Comprehensive Cancer Network makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. This publication should not be used for commercial purpose. It is provided for free to Chinese medical professions with the support of the unrestrictive educational grant of Bayer Healthcare Co. Ltd. which exerts no influence to the formation of the Chinese edition of NCCN Clinical Practice Guidelines in Oncology-Kidney Cancer GuiFishman, MD, PhD † ‡ Þ H. Lee Moffitt Cancer Center & Research Institute Steven L. Hancock, MD § Þ Stanford Comprehensive Cancer Center Gary R. Hudes, MD † ‡ Fox Chase Cancer Center Eric Jonasch, MD † The University of Texas M. D. Anderson Cancer Center Timothy M. Kuzel, MD † ‡ Robert H. Lurie Comprehensive Cancer Center of Northwestern University Paul H. Lange, MD ω Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance Ellis G. Levine, MD † Roswell Park Cancer Institute Kim A. Margolin, MD † ‡ Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance M. Dror Michaelson, MD, PhD † Massachusetts General Hospital Cancer Center Thomas Olencki, DO ‡ The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute